When Newlux peak
The global biotechnology sector has witnessed unprecedented growth in therapeutic protein development, with market projections exceeding $450 billion by 2030. Amidst this expansion, Newlux Corporation has emerged as a critical player through its proprietary cell line engineering platform. Their recent breakthrough in glycosylation patterning demonstrates measurable impacts on drug efficacy – Phase III trials showed …